Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Twist Bioscience And bitBiome Announced The Launch Of A Joint Transaminase Enzyme Screening Kit

Author: Benzinga Newsdesk | August 05, 2024 08:04am

Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and bitBiome Inc., a biotechnology company unlocking the potential of our planet's microbes to power the future of the bioeconomy, today announced the launch of a joint Transaminase Enzyme Screening Kit, which is a curated collection of forty-eight highly diverse transaminase enzymes ready for in-house screening and evaluation.

Posted In: TWST

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist